Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China · Delayed Price · Currency is CNY 31.17
-2.93 (-8.59%)
Aug 21, 2026, 3:00 PM CST
SHA:688062 Market Cap
SHA:688062 has a market cap or net worth of 13.3 billion as of August 21, 2026. Its market cap has decreased by -9.28% in one year.
Market Cap
13.30B
Enterprise Value
15.26B
Revenue
745.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.17
ChartMarket Cap Chart
Since January 18, 2022, SHA:688062's market cap has increased from 9.79B to 13.30B, an increase of 35.90%. That is a compound annual growth rate of 6.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 14.48B | -5.77% |
| Dec 31, 2025 | 15.36B | 90.35% |
| Dec 31, 2024 | 8.07B | -38.21% |
| Dec 29, 2023 | 13.06B | 126.23% |
| Dec 30, 2022 | 5.77B | -41.02% |
| Jan 18, 2022 | 9.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BrightGene Bio-Medical Technology | 16.91B |
| Acrobiosystems | 16.16B |
| Sino Biological,Inc. | 16.00B |
| HitGen | 15.51B |
| GemPharmatech | 15.01B |
| Shanghai Medicilon | 14.47B |
| Jinyu Bio-technology | 14.31B |
| Anhui Anke Biotechnology (Group) | 14.10B |